Target- |
MechanismStem cell replacements |
|
|
|
|
Drug Highest PhasePhase 1/2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingPhase 1IIT Phase II Clinical Trial to Determine the Safety and Efficacy of the Allogeneic Use of Expanded Mesenchymal Stem Cells Derived from Adipose Tissue (HC106) in the Local Treatment of Female Urinary Incontinence in Women Over 50 Years of Age
Evaluate the feasibility and safety, obtaining initial efficacy data, of expanded allogeneic mesenchymal stem cells derived from adipose tissue (HC106) for the treatment of urinary incontinence in women over 50 years of age.
/ Not yet recruitingNot ApplicableIIT Impact on Quality of Life and Burden of Disease in Adults With Herpes Zoster
Title: Impact on quality of life and disease burden in adults with herpes zoster
Prospective cohort study for the primary objective and the secondary objectives (1 and 2) and retrospective cohort study for the secondary objective 3.
Disease or disorder under study: Patients with a herpes zoster (HZ) diagnosis.
/ CompletedNot ApplicableIIT PPI in the Design and Conduct of Non-pharmacological, Non-commercial Spanish Clinical Trials Completed and Published in 2009-2024
Patient and public involvement (PPI) in the design and conduct of clinical trials has been encouraged for many years. Yet, there is no data available describing how many trials sponsored by non-commercial Spanish individuals or organizations have liaised with patients, relatives or caregivers and the public to consider their preferences and values in the design of trials assessing non-pharmacological interventions.
100 Clinical Results associated with Fundación Instituto de Investigación Sanitaria Fundación Jimen
0 Patents (Medical) associated with Fundación Instituto de Investigación Sanitaria Fundación Jimen
100 Deals associated with Fundación Instituto de Investigación Sanitaria Fundación Jimen
100 Translational Medicine associated with Fundación Instituto de Investigación Sanitaria Fundación Jimen